Managing Relapse Patients Early On After Initial Therapy  Clinical Trial Participation is Preferred

Managing Relapse Patients Early On After Initial Therapy Clinical Trial Participation is Preferred

hematologydebates

1 year
48 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Grzegorz S. Nowakowski, M.D., Mayo Clinic, explains Managing Relapse Patients Early On After Initial Therapy Clinical Trial Participation is Preferred at Imedex Great Debates 2018.
Up Next Autoplay